Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes.
Efficacy and safety of a once-a-day human GLP-1 analog liraglutide vs glibenclamide monotherapy in Japanese patients with type 2 diabetes